Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (2): 199-203. doi: 10.19723/j.issn.1671-167X.2020.02.001

    Next Articles

  

  • Online:2020-04-18 Published:2020-04-18

RICH HTML

   

PDF (PC)

CLC Number: 

  • R730.5
[1] Liang W, Guan W, Chen R , et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China[J]. Lancet Oncol, 2020,21(3):335-337.
[2] Guan WJ, Ni ZY, Hu Y , et al. Clinical characteristics of 2019 novel coronavirus infection in China [J/OL]. N Engl J Med,( 2020-02-28)[2020-02-29]. doi: 10.1056/NEJMoa2002032.
[3] 中华人民共和国国家卫生健康委员会,国家中医药管理局. 新型冠状病毒感染的肺炎诊疗方案(试行第六版)[EB/OL]. ( 2020- 02- 18)[2020-02-23]. .
[4] 李妍, 徐胜勇, 杜铁宽 , 等. 新型冠状病毒肺炎临床特点及筛查流程探讨[J]. 中华急诊医学杂志, 2020,29(3):336-340.
[5] Tsukuma H, Oshima A, Narahara H , et al. Natural history of early gastric cancer: A non-concurrent, long term, follow up study[J]. Gut, 2000,47(5), 618-621.
[6] Oh SY, Lee JH, Lee HJ , et al. Natural history of gastric cancer: Observational study of gastric cancer patients not treated during follow-up[J]. Ann Surg Oncol, 2019,26(9):2905-2911.
[7] 李阳, 李占飞, 毛庆祥 , 等. 新冠肺炎疫情期间严重创伤紧急手术及感染防护专家共识[J]. 中华创伤杂志, 2020,36(2):97-103.
[8] 中华医学会肠外肠内营养学分会. 关于新型冠状病毒肺炎患者的医学营养治疗专家建议[R/OL]. ( 2020-01-30)[2020-02-23].
[9] 石汉平, 许红霞, 李苏宜 , 等. 营养不良的五阶梯治疗[J].肿瘤代谢与营养电子杂志, 2015(1):35-39.
[10] 国务院办公厅转发国家卫生健康委,人力资源社会保障部,财政部关于改善一线医务人员工作条件切实关心医务人员身心健康若干措施的通知[EB/OL]. ( 2020- 02- 11)[2020-02-23]. .
[11] Cruz AT, Patel B, Distefano MC , et al. Outside the box and into thick air: Implementation of an exterior mobile pediatric emergency response team for North American H1N1 (Swine) influenza virus in Houston, Texas[J]. Ann Emerg Med, 2010,55(1):23-31.
[12] Weiss EA, Ngo J, Gilbert GH , et al. Drive-through medicine: A novel proposal for rapid evaluation of patients during an influenza pandemic[J]. Ann Emerg Med, 2010,55(3):268-273.
[1] Dingyi CHEN, Haoxin DU, Yichen ZHANG, Yanfei WANG, Wei LIU, Yuanyuan JIAO, Luwen SHI, Xiaodong GUAN, Xinpu LU. Impact of palliative care on medication use and medical utilization in patients with advanced cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 996-1001.
[2] Jie LIU, Mingwei MA, Qing'an WANG, Ming SHI, Jinpeng YIN, Zhanping WANG, Jingtao SHEN, Xianshu GAO. Comparison of setup errors between two immobilization methods in prostate cancer radiotherapy based on cone-beam computed tomography [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 692-697.
[3] Suqing TIAN, Haitao SUN, Tiandi ZHAO, Wei WANG. Analysis of positioning errors in head and neck cancers during radiotherapy assisted by the 6D treatment couch and image-guided radiation therapy [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1097-1100.
[4] Xiao-jing CHENG,Dong JIANG,Lian-hai ZHANG,Jiang-hua WANG,Ya-zhen LI,Jia-hui ZHAI,Bao-qi YAN,Lu-lu ZHANG,Xing-wang XIE,Zi-yu LI,Jia-fu JI. Preclinical study of T cell receptor specifically reactive with KRAS G12V mutation in the treatment of malignant tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 884-895.
[5] Li ZHANG,Ji-fang GONG,Hong-ming PAN,Yu-xian BAI,Tian-shu LIU,Ying CHENG,Ya-chi CHEN,Jia-ying HUANG,Ting-ting XU,Fei-jiao GE,Wan-ling HSU,Jane SHI,Xi-chun HU,Lin SHEN. Atezolizumab therapy in Chinese patients with locally advanced or metastatic solid tumors: An open-label, phase Ⅰ study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 971-980.
[6] DING Ting-ting,ZENG Chu-xiong,HU Li-na,YU Ming-hua. Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 203-208.
[7] GU Yang-chun,LIU Ying,XIE Chao,CAO Bao-shan. Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 369-375.
[8] . [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 597-602.
[9] . [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 204-206.
[10] Yan TIAN,Jun ZHU. Relationship between p53 rs1625895 polymorphism and prognosis in diffuse large B-cell lymphoma [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 791-796.
[11] WU Peng-hui, XIE Yao, ZHAO Wei-hong, HUA Ying, SUN Qing, LI Shuo, WU Ye, LU Xin-tian. Clinical characteristics analysis of children with reversible posterior leukoen-cephalopathy syndrome during the treatment of hematological tumor [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 662-665.
[12] ZHU Yan，SHI Yong-jin，ZHAO Yu-liang, ZHU Ping. Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 318-325.
[13] YE Ke-qiang, HUANG Ming-wei, LI Jun-li, TANG Jin-tian, ZHANG Jian-guo. Simulation of dose distribution in bone medium of 125I photon emitting source with Monte Carlo method [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 131-135.
[14] SUN Hai-tao, YANG Rui-jie, JIANG Ping, JIANG Wei-juan, LI Jin-na, MENG Na, WANG Jun-jie. Dosimetric analysis of volumetric modulated arc therapy and intensity modulated radiotherapy for patients undergone breast-conserving operation [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 188-192.
[15] LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin. Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 840-846.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd